Results 351 to 360 of about 622,986 (383)

Fas and Fas Ligand in Autoimmunity

1999
I R, Rifkin, A, Marshak-Rothstein
openaire   +2 more sources

Fas/Fas Ligand

2014
Estrella García-González, Enrico Selvi
openaire   +1 more source

Generalized lymphoproliferative disease in mice, caused by a point mutation in the fas ligand

Cell, 1994
Tomohiro Takahashi, Masato Tanaka, C. I. Brannan, N. Jenkins, N. Copeland, T. Suda, S. Nagata   +6 more
semanticscholar   +1 more source

Tumor necrosis factor receptor and Fas signaling mechanisms.

Annual Review of Immunology, 1999
D. Wallach, E. Varfolomeev, N. Malinin, Y. Goltsev, A. Kovalenko, M. Boldin   +5 more
semanticscholar   +1 more source

Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas

Nature, 1995
T. Brunner, R. Mogil, D. Laface, N. Yoo, A. Mahboubi, F. Echeverri, Seamus J. Martin, W. R. Force, D. Lynch, C. Ware, D. Green   +10 more
semanticscholar   +1 more source

Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity.

Science, 1995
F. Rieux-Laucat, F. Deist, C. Hivroz, I. Roberts, K. Debatin, A. Fischer, J. D. Villartay   +6 more
semanticscholar   +1 more source

Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escape

Science, 1996
M. Hahne, D. Rimoldi, M. Schröter, P. Romero, M. Schreier, L. French, P. Schneider, Thierry Bornand, A. Fontana, D. Liénard, J. Cerottini, J. Tschopp   +11 more
semanticscholar   +1 more source

FAS

2011
  +6 more sources

FAS (CD95) and FAS Ligand

1998
Mark R. Alderson, David H. Lynch
openaire   +1 more source

Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule.

Science, 1994
Jianhua Cheng, T. Zhou, Changdan Liu, J. Shapiro, Matthew J. Brauer, M. Kiefer, P. Barr, J. Mountz   +7 more
semanticscholar   +1 more source